The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
His posts confounds me , in the same diatribe so many contradictions
Agree he’s mental.
I think you are right Whimax poor Goup's getting on a bit and is getting worried about time scales with NFX. I think he's beginning to think he's trapped in here but has not got the guts to sell up and move on in case he misses out on a blockbuster.
Goup. How many times/ways are you going to keep repeating the same point ffs. You’re going round in circles here (and it’s not a very big circle).
You are also constantly posting as if the world HASN’T been shut down for 4 months, which is absolutely ridiculous imo. You have wound yourself up so much that you’re not thinking clearly any longer. I honestly think it’s time you decided whether you want to be in or out of this share. If you’re in, I suggest you step away from the keyboard for a week or 2, otherwise you’re going to do yourself a mischief!
Calm down man, for the love of god!!
Your got 001 and 002 but come June we have nothing ,
Like random said I have been here from the start but we have had the person in the wrong place ,
The bod changes said a lot , there must have been a upheaval,
I think I the upheaval was over deals .I not seeking anything other than a decent honest company and I think naivety
Randoml I liked what I see in the old days,at the time I wasn't aware dan was not a negotiationer ,
I think I have learnt that and admit I fell for his podcast,
The fact the bod have a lot of skin in here is the thing that keeps me going ,
I hope karl keegan can bring his experience to the game,
I think they have drawn a line and we are seeing a new beginning,
Personally I don't think after all this time we have a Japan deal ,covid gives them an excuse , nothing happens quickly ,in the old days we were a year behind predicted schedule. But you can't keep promising jam tomorrow it catches up on you ,for 9 months schedule has been missed and that's poor , like I say I hope karl keegan points Dan in the right direction to date we have ebers and the new company,
Dan always boasts have quick the method is but produced nowt ,
You can only live on what's a positive rns and the market don't go on his uncertainty,
We are just about the worst performing pharma at present
Dan stated last feb in podcast that they were in discussions with a preferred partner. Out of curiosity does anybody remember did say Japan rights , had a feeling he did? In last RNS he mentions Pan Asian deal so just wondering if the narrative has changed hence change in strategy?
Hi Random I think Yatai just don't have a pot to pee in hence they'll try to save 2.5m and the rest by disbanding NSB as Soup suggested. Hopefully lesson learnt not to deal with China now and the link should show they are millions in debt.
https://www.marketwatch.com/investing/stock/002370/profile?countrycode=cn
With regards to NXP002 it is still touted as their blockbuster drug on the last RNS with Vistagen. Dr Thillai and Keegan have also taken options/warrants of 6000000 and 3000000 shares respectively and must know this is all dependant on NXP002 otherwise they are not making any money.
Keegan's warrants are at 6.75p.
Ps. The company rns states they are talking to multiple prospective partners.
Random, why would it be just a single preferred partner, different companies only cover certain regions. It’s likely that one company won’t take rights to all territories.
Groupplease came across the old Levrett Bb a couple weeks ago. Doesn’t appear to be any of the original posters left here except you and me. Been here a long time!!
https://www.lse.co.uk/ShareChat.asp?ShareTicker=LVRT&share=Lvrtl&page=36
Greggscottie I guess I am not saying NXP002 is worthless , just starting to think it mightened be the transformational news Dan hyped it up to be! Are we still trying to crack a deal with the preferred partner or is it partner B?
Or like yetai have decided to do, walk away during the due diligence process! Surely that the exchange of technical information was for a reason ? On a positive note here the cannabinoid route would appear very positive but I have big concerns about NXP001 & NXP002!
Random, if Kissei are the preferred partner due to market size, abilith to make bigger returns for NFX, willing to offer a bigger % etc etc etc....then why wouldnt you wait.
This makes sense unless you are shorting, want a lower entry price or some other random reason.
Let's hope karl keegan can see through dans mess and come up with the goods:
Dans lab material , don't let him loose ever again on a podcast .
Not one word has come good
Agreed random , no rns needed,
I acknowledge I have made mistakes backing a Dan led nfx, his podcast turned out rotten to the core ,
Hope he's been sorted, the Japan deal is as dead as his China one imho
Talk about a podcast ramp , we are main market , leave it alone , close ?it was never on .
Somebody mentioned that NFX would need to RNS if a failure of deal with Kessei happened. No they wouldn’t cause it wasn’t never stated in RNS to begin with!
Dan said there was multiple companies interested in NXP002, if what you say were true they surely wouldn’t be hanging about waiting for kessei to sort their affairs in order. I am starting to draw similar conclusions to events as groupplease! From Dans podcasts at start of year and his predicted dates for finalising deal with Kessei , I feel Covid 19 isn’t the real reason why a deal wasn’t finalised!
Goup,
I explained mg thoughts on why there have been delays (other than covid).
Kissei have 2 people on the board who have spent a long time on tranikast. 1 brought it to market, 1 failed twice to improve its efficacy. Then Dan pops up and says we have the key to improve tranilast that you couldn't find.
Japanese culture means no one wants to lose face.. so NFX will likely have to meander a way through to the deal whilst not rubbing salt in the wound. They will need to be seen to be working with Kissei...so lots oc data will need to flow between the parties.
I expect the deal to be done soon, and hope it to be in place for the fy results in early July.
All the best...
Halespur , no company was act mentioned in the price movement rns.
All the Japan deal has been newspaper and bb led so surely an rns is not essential.
Too much time has elapsed approx 7 months , the deal should have been down to dotting the I crossing the t's even with covI'd 19 .you're clinging to straws
My feeling that deal is as dead as China. I'm not saying something else is on thr horizon,
Nuformix has established a broader range of assets, opportunities and revenue sources that ought to mitigate such risks. From the rns ,
The company's floundering under the old bod , the new bod needs to draw a line quickly , so much has gone out the window ,
You can have a good scientists but when it comes to pr and financial they are out their depths, that it what we have seen here , Dan is not the right man to take this company fowards , Karl keegan is . Afraid I have not got years waiting,
Goup if the Japan deal was dead Dan would have had to say so in the RNS. Discussions are ongoing but delayed by COVID due to the logistics of key personnel i.e. lockdown = less people in the offices, labs and work. Japan and the ROW is opening up for business although air travel is still limited.
I know the VistaGen website link has been posted a couple of times but no offence its exactly the same quotes/information in our RNS.
To keep #Nuformix in the UK with patents .
For me the Japenese deal is dead and China deader.